Molecular diagnostics has jump-started the use of high technology in the clinical lab. Although it has been a slower than anticipated adoption in the clinical laboratory setting, molecular diagnostics has begun to overcome the impediments of incomplete genetic knowledge, the development of new technology platforms, and the communication of their use and efficacy to lab personnel and clinicians alike.

A series of technologies developed over the years to address the challenges of molecular diagnostics include eight major areas: amplification technologies (gene and signal), blotting technologies, electrophoretic technologies, microarray technologies, probe technologies, restriction fragment-length polymorphism (RFLP) analysis, RNA inhibition analysis, and single nucleotide polymorphism (SNP) analysis and software. Further, there is significant overlap among these technologies in that they can support one another. These developments have set the stage for excellent growth potential in this marketplace.

Kalorama’s Molecular Diagnostics: Major World Markets completely re-examines the molecular diagnostics market and expands its well respected previous editions. The report features:

• Market Potential in terms of number of tests (testing volume) and market size (dollar volume) through 2016 for strategic planning and new product consideration.
• 110 Tables and Figures detailing the data and trends in each country and segment/subsegment for quick reference and encorporation into proposals, internal memos and business plans.
• In-depth Profiles (averaging 5 pages each) of top 10 competitors, detailing product offerings, recent announcements and acquisitions, and strategies..
• Discussion of the Major Technologies, including developments, products, benefits and drawbacks of:
  • amplification technologies (gene and signal)
  • blotting technologies
  • electrophoresis technologies
  • microarray technologies
  • probe technologies
  • restriction fragment-length polymorphism (RFLP)
  • RNA inhibition analysis
  • single nucleotide polymorphism (SNP) analysis
• 14 High Level Conclusions about the marketplace, each with a discussion of its strategic implication to assist executives in understanding how the trends and data affect their business decisions.
• Two tables (over 70 pages in length) list both marketed products and key “home-brew” molecular tests currently in use.

(The U.S. Market for Molecular Diagnostics) to include all seven of the major world healthcare markets, including:

• France
• Germany
• Italy
• Japan
• Spain
• The United Kingdom
• The United States

This definitive and comprehensive assessment of the molecular diagnostics market provides market potential in both testing volume and dollar volume for each major country in the following test segments and subsegments:

• Blood Banking and Plasmapheresis
  • Human Immunodeficiency Virus (HIV)
  • Hepatitis C Virus (HCV)
  • Hepatitis B Virus (HBV)
  • Hepatitis A Virus (HAV)
  • Human T-Cell Lymphotropic Virus (HTLV)
  • West Nile Virus (WNV)
  • Other
• Genetic Analysis
  • Heterozygote Testing
  • Presymptomatic Testing
  • Prenatal Testing
  • Newborn Screening
• Oncology
  • Cancer Management
  • Cancer Susceptibility
• Pharmacogenetics
  • HIV/AIDS
  • Neuropharmacology
  • Immune Disease
  • Cancer
  • Other
• Infectious Disease
  • Chlamydia trachomatis (CT)
  • Neisseria gonorrhoeae (NG)
  • Pneumonia
  • Human Immunodeficiency Virus (HIV)
  • Hepatitis B Virus (HBV)
  • Hepatitis C Virus (HCV)
  • Humanpapilloma Virus (HPV)
  • Mycobacterium tuberculosis (MT) (Tuberculosis [TB])
  • Herpes Simplex Virus (HSV)
  • West Nile Virus (WNV)

The report also details the technologies and products competing and shaping the markets, describes the market characteristics of the various segments, provides 14 vital conclusions along with their strategic implications for marketers, and profiles in depth the top market participants.

The analysis presented in this report is based on data from a combination of company, government, industry, and institutional and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including molecular biologists, laboratory medicine professionals, pathologists, research scientists, business development managers and marketing managers.

Related Reports:

Smoking Cessation: World Markets
Nov 1, 2008 - KLI1646594 - $3,500.00

Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
Nov 1, 2008 - KLI1816262 - $3,995.00

Glucose Testing Markets
Nov 1, 2008 - KLI1911068 - $1,995.00

HIV: Markets for Diagnostics and Therapeutics
Oct 1, 2008 - KLI1646600 - $3,500.00

Kalorama Medical Device Market Research Bundle: Infusion Pumps, Minimally Invasive Devices, Syringes, Hip and Knee Implants, Respiratory Equipment, Asian Device Markets, OEM Contract Manufacturing, Reusable Equipment, Catheters)
Oct 1, 2008 - KLI1927457 - $9,995.00

Worldwide In Vitro Diagnostics Market Research Bundle (Worldwide Market for In Vitro Diagnostic Tests, SNP Genotyping Markets, Companion Diagnostics, Testing Services Markets)
Oct 1, 2008 - KLI1927625 - $7,995.00

Minimally Invasive Surgical Devices, World Market
Sep 1, 2008 - KLI1614100 - $3,500.00

The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)
Aug 1, 2008 - KLI1614113 - $2,995.00

World Market for Respiratory Equipment and Disposables, 3rd. Edition
Aug 1, 2008 - KLI1676679 - $2,995.00

Lab Automation Markets Worldwide (Next-Generation Systems, Key Companies, Forecasts and Trends)
Aug 1, 2008 - KLI1670001 - $3,500.00